Last Updated: 05-Aug-2026

Surgical and Isolation Gown Market Size, Share, Growth, and Industry Analysis, By Type (Full-back Isolation Gowns, Open-back Protective Gowns, Others), By Application (Hospitals, Ambulatory and Surgical Centers, Clinics, Others), Regional Insights and Forecast to 2035

$1860.02M
2025 Market Size
Base Year Value
$2431.49M
By 2035
Forecast Value
3.02%
CAGR
2026 - 2035
9 Yrs
Coverage
Forecast Period

Surgical and Isolation Gown Market Overview

The global Surgical and Isolation Gown Market size estimated at USD 1860.02 million in 2026 and is projected to reach USD 2431.49 million by 2035, growing at a CAGR of 3.02% from 2026 to 2035.

The Surgical and Isolation Gown Market is driven by infection-control requirements, surgical procedure volumes, hospital procurement, and demand for certified protective apparel. Disposable gowns remain dominant because they simplify sterilization management and reduce cross-contamination risk. In healthcare settings, gowns are commonly classified by protection levels, fluid resistance, material, and intended procedure. Hospitals and ambulatory surgical centers represent major consumption channels, while high-risk procedures increasingly require reinforced protection zones. 

The USA Surgical and Isolation Gown Market remains one of the largest demand centers because of extensive hospital infrastructure, high surgical activity, stringent infection-prevention practices, and substantial purchasing by integrated healthcare systems. Disposable protective gowns account for a significant portion of institutional consumption, particularly for operating rooms, intensive-care units, emergency departments, and isolation areas. Hospitals and surgical centers increasingly prioritize fluid-resistant and standardized protective apparel. Demand is also supported by recurring replacement requirements, with high-volume facilities purchasing gowns in large standardized lots. 

Key Findings

  • Key Market Driver: Approximately 65%–75% of institutional purchasing decisions are influenced by infection prevention, fluid resistance, barrier protection, and compliance requirements, supporting recurring gown replacement and standardized procurement.
  • Major Market Restraint: Material costs, disposal requirements, supply-chain volatility, and procurement price pressure collectively influence roughly 25%–35% of purchasing considerations, especially for facilities operating under strict healthcare expenditure controls.
  • Emerging Trends: Breathable nonwoven fabrics, ergonomic designs, reinforced critical zones, antimicrobial treatments, and lower-plastic solutions collectively represent an estimated 30%–40% of new product development priorities.
  • Regional Leadership: North America is estimated to represent approximately 30%–35% of global demand, followed by Europe at about 25%–30%, while Asia-Pacific contributes approximately 25%–30%.
  • Competitive Landscape: Leading multinational and specialized manufacturers collectively account for an estimated 35%–45% of organized institutional supply, with remaining demand distributed among regional manufacturers and private-label suppliers.
  • Market Segmentation: Full-back isolation gowns represent approximately 45%–55% of demand, open-back protective gowns about 25%–35%, and other specialized formats approximately 15%–25%.
  • Recent Development: Approximately 20%–30% of product-development activity is increasingly directed toward improved breathability, material efficiency, fluid-barrier performance, ergonomic fit, and sustainability-oriented construction.

The Surgical and Isolation Gown Market is increasingly characterized by higher-performance barrier fabrics, standardized protection classifications, and product designs that balance protection with wearer comfort. Disposable gowns continue to dominate high-throughput clinical environments, while demand for fluid-resistant materials is particularly strong in operating rooms and procedures involving blood or bodily-fluid exposure. Industry purchasing teams are increasingly evaluating tensile strength, seam integrity, liquid penetration, lint generation, and packaging efficiency. Approximately 60%–70% of routine hospital gown requirements are associated with disposable formats, while reusable products maintain relevance where laundering infrastructure and sustainability programs are established.

Another important Surgical and Isolation Gown Market Trend is the development of lighter multilayer fabrics with improved breathability. Manufacturers are concentrating on reinforced sleeves, chest zones, and front panels for higher-risk procedures. Demand for latex-free materials is also increasing because healthcare facilities seek to minimize allergen exposure. Private-label procurement and bulk contracting remain important, with large hospital systems increasingly emphasizing standardized gown specifications. Sustainable materials, reduced packaging, recyclable components, and lower fabric consumption are becoming relevant purchasing criteria, particularly in developed markets where healthcare organizations are targeting reductions in medical-waste intensity.

Surgical and Isolation Gown Market Dynamics

DRIVER

"Rising infection-prevention requirements"

Infection prevention remains a primary Surgical and Isolation Gown Market growth driver as healthcare facilities require reliable barriers against blood, body fluids, microorganisms, and contaminated surfaces. Hospitals perform large numbers of surgical and invasive procedures in which protective gowns are routinely integrated into infection-control protocols. Approximately 65%–75% of institutional gown procurement decisions can be associated with barrier protection. 

RESTRAINTS

"Procurement cost and medical-waste pressure"

Cost sensitivity is a significant restraint because surgical and isolation gowns are purchased repeatedly in large quantities, creating substantial cumulative procurement expenditure even when individual unit prices remain relatively low. Disposable gowns can also increase medical-waste volumes, while healthcare institutions face pressure to control plastic consumption and disposal intensity. 

OPPORTUNITY

"Development of sustainable high-performance gowns"

Sustainable product development represents a significant Surgical and Isolation Gown Market opportunity as hospitals seek to reduce environmental impact without compromising clinical protection. Manufacturers can target lighter fabrics, optimized packaging, recyclable components, lower material consumption, and reusable systems supported by efficient sterilization infrastructure. Approximately 30%–40% of new product-development priorities can increasingly be linked to sustainability, comfort, material efficiency, or waste reduction. 

CHALLENGE

"Balancing protection, comfort, and supply reliability"

The major challenge is achieving high barrier protection without producing excessive heat, restricted movement, stiffness, or wearer fatigue. Surgical personnel can spend several hours in gowns, making breathability and ergonomic fit important alongside liquid resistance. Manufacturers must also maintain consistent raw-material quality and production capacity while responding to fluctuations in healthcare demand. 

Surgical and Isolation Gown Market Segmentation

The Surgical and Isolation Gown Market is segmented primarily by gown construction and application. By type, Full-back Isolation Gowns, Open-back Protective Gowns, and Others address different protection, mobility, and clinical-use requirements. By application, Hospitals represent the largest institutional demand center, followed by Ambulatory and Surgical Centers, Clinics, and other healthcare facilities. Procurement patterns differ according to procedure intensity, infection-control protocols, patient throughput, gown protection level, disposable-versus-reusable preferences, and healthcare infrastructure.

Global Surgical and Isolation Gown Market Size, 2035

BY TYPE

Full-back Isolation Gowns: Full-back Isolation Gowns represent a major portion of protective apparel demand because they provide broader body coverage than open-back configurations and are widely suited to isolation rooms, infectious-disease management, intensive-care environments, and procedures where exposure risk is elevated. This format is estimated to account for approximately 45%–55% of the overall gown type mix. Full-back designs can incorporate elastic or knitted cuffs, waist ties, neck closures, fluid-resistant layers, and reinforced protection zones. Disposable polypropylene-based gowns remain widely used because they are lightweight and economical for high-volume environments. Higher-performance constructions increasingly use multilayer nonwoven materials to improve barrier protection while retaining mobility. 

Open-back Protective Gowns: Open-back Protective Gowns are commonly selected when ease of movement, ventilation, rapid donning, and procedural convenience are important. They are estimated to represent approximately 25%–35% of the Surgical and Isolation Gown Market type mix. These gowns can be used across clinical environments where complete rear coverage is less critical or where the procedure has a comparatively controlled exposure profile. Open-back formats can reduce fabric consumption and may provide greater wearer comfort in warm operating environments. Demand is supported by clinics, ambulatory facilities, examination areas, and selected procedural applications. 

Others: The Others category includes specialized surgical gowns, reinforced gowns, reusable gowns, antimicrobial-treated formats, pediatric configurations, and application-specific protective apparel. This segment accounts for approximately 15%–25% of demand and provides manufacturers with opportunities to differentiate products through technical performance. Reinforced surgical gowns are particularly relevant for procedures involving substantial fluid exposure, with additional protection often concentrated around the chest, abdomen, forearms, or sleeves. Reusable gowns maintain relevance in institutions with established sterilization and laundering infrastructure, while specialty disposable gowns are preferred where rapid turnover is required. 

BY APPLICATION

Hospitals: Hospitals represent the largest application segment, accounting for an estimated 60%–70% of overall institutional Surgical and Isolation Gown Market consumption. High patient volumes, operating rooms, intensive-care units, emergency departments, infection-isolation areas, and inpatient procedures generate continuous demand. Large hospitals typically purchase gowns through centralized procurement systems and may standardize specifications across multiple departments. Disposable gowns dominate high-throughput areas because they simplify turnaround and reduce dependence on laundering capacity. 

Ambulatory and Surgical Centers: Ambulatory and Surgical Centers are important users because they conduct high volumes of planned procedures while emphasizing efficient patient turnover and controlled operating costs. This application is estimated to represent approximately 15%–20% of Surgical and Isolation Gown Market consumption. These facilities frequently require gowns that combine barrier performance, lightweight construction, rapid donning, and convenient disposal. Surgical gowns with reinforced front zones and sleeves are particularly relevant for procedures involving increased fluid exposure. Approximately 50%–60% of purchasing decisions in these environments may prioritize ease of use, procedure-specific protection, and inventory efficiency.

Clinics: Clinics represent a diversified application segment covering outpatient consultation, minor procedures, diagnostic interventions, wound management, and infection-control activities. Clinics are estimated to account for approximately 8%–12% of market demand, with requirements varying considerably according to specialty. High-use clinics typically prefer lightweight disposable gowns that can be quickly deployed and discarded, while specialty facilities may require stronger fluid barriers. Procurement decisions are often more price-sensitive than those of large hospitals, increasing interest in standardized multipurpose products. Approximately 40%–50% of clinic gown requirements can be related to routine examination and minor procedural use. 

Others: The Others application segment includes long-term care facilities, diagnostic centers, home healthcare, emergency-response organizations, rehabilitation facilities, laboratories, and specialized healthcare environments. It represents approximately 8%–15% of total demand and is characterized by diverse protection requirements. Long-term care and home healthcare can require gowns for infection isolation and routine exposure management, while laboratories may prioritize fluid protection and contamination control. Demand can fluctuate according to infectious-disease activity, institutional protocols, and emergency preparedness. 

Surgical and Isolation Gown Market Regional Outlook

The regional structure of the Surgical and Isolation Gown Market reflects healthcare expenditure, surgical procedure volumes, infection-control standards, manufacturing capacity, and hospital procurement systems. North America is estimated to hold approximately 30%–35% of global demand, Europe about 25%–30%, and Asia-Pacific approximately 25%–30%, together representing around 85% of the market. Middle East and Africa account for the remaining approximately 15% when combined with smaller regional markets and differences in product classification. 

Global Surgical and Isolation Gown Market Share, by Type 2035

NORTH AMERICA

North America represents approximately 30%–35% of the global Surgical and Isolation Gown Market, supported by extensive hospital infrastructure, high surgical activity, strong infection-prevention programs, and established medical-supply procurement systems. The United States accounts for the majority of regional demand, while Canada contributes a smaller but stable share. Disposable gowns are widely preferred in high-throughput environments, particularly operating rooms, intensive-care units, emergency departments, and isolation facilities. Approximately 65%–75% of institutional consumption is estimated to involve disposable formats. Buyers increasingly prioritize fluid resistance, standardized protection levels, consistent sizing, and supply continuity. Domestic and regional sourcing strategies have gained importance as healthcare organizations seek to reduce exposure to international logistics disruptions. Sustainability is also influencing procurement, with approximately 20%–30% of purchasing discussions increasingly incorporating packaging reduction, material efficiency, or waste-management considerations. North America remains a major center for premium and specialized gown demand.

EUROPE

Europe accounts for approximately 25%–30% of global Surgical and Isolation Gown Market demand, supported by mature healthcare systems, structured infection-control practices, surgical facilities, and strong institutional purchasing. Germany, the United Kingdom, France, Italy, and other Western European markets contribute substantially to regional consumption. Disposable products remain widely used, although reusable gown systems have opportunities in healthcare organizations pursuing circular-economy objectives. Approximately 55%–70% of regional demand is estimated to favor disposable formats, depending on application and procurement policy. European buyers increasingly evaluate product safety, barrier performance, worker comfort, packaging, and environmental footprint simultaneously. Around 25%–35% of product-selection criteria can increasingly incorporate sustainability or waste-reduction considerations. Manufacturers are responding with lighter materials, recyclable packaging, improved fabric efficiency, and optimized gown designs. European procurement also emphasizes reliable documentation, standardized product performance, and stable supply arrangements for large healthcare networks.

GERMANY Surgical and Isolation Gown Market

Germany represents an estimated 7%–9% of the European Surgical and Isolation Gown Market and approximately 2%–3% of global demand. The country’s large hospital network, established surgical infrastructure, and strong infection-control practices support consistent gown consumption. Disposable protective gowns are particularly important in operating rooms, intensive-care settings, isolation areas, and emergency departments. Approximately 60%–70% of institutional requirements are estimated to involve disposable formats, while reusable solutions remain relevant where sterilization infrastructure is available. German procurement increasingly considers fluid barrier performance, fabric quality, ergonomic fit, product consistency, and environmental impact. Approximately 25%–35% of procurement evaluations can include sustainability-related factors such as material efficiency and packaging reduction. Domestic distributors and healthcare procurement organizations emphasize continuity of supply and standardized specifications. Advanced breathable nonwoven fabrics, reinforced surgical designs, and lower-lint materials are becoming increasingly relevant to premium hospital procurement.

UNITED KINGDOM Surgical and Isolation Gown Market

The United Kingdom represents approximately 5%–7% of the European Surgical and Isolation Gown Market and around 1.5%–2.5% of global demand. Demand is concentrated across hospitals, surgical centers, emergency departments, community healthcare, and specialist facilities. Infection-control protocols and centralized procurement strongly influence gown specifications and supplier selection. Disposable gowns represent a substantial share of consumption, particularly in high-throughput hospital departments, while reusable solutions are receiving attention where healthcare organizations pursue waste-reduction targets. Approximately 60%–70% of institutional gown demand is estimated to involve disposable products. Buyers increasingly assess fluid resistance, comfort, fit, protection level, packaging efficiency, and supply reliability. Approximately 20%–30% of procurement priorities are increasingly connected to sustainability, waste reduction, or improved material efficiency. The United Kingdom market continues to favor standardized products capable of supporting consistent procurement across multiple healthcare facilities.

ASIA-PACIFIC

Asia-Pacific represents approximately 25%–30% of global Surgical and Isolation Gown Market demand and is also a major manufacturing hub for disposable protective apparel. China, Japan, South Korea, India, Australia, and Southeast Asian economies collectively create a broad demand base. The region benefits from expanding hospital infrastructure, increasing surgical capacity, greater infection-control awareness, and growing healthcare expenditure. Approximately 55%–70% of demand in developed Asian markets is associated with disposable gown formats, while price-sensitive markets can show stronger preference for economical constructions. Asia-Pacific manufacturers also supply substantial volumes to international markets, supporting economies of scale and product diversification. Approximately 30%–40% of regional production activity is increasingly oriented toward improved barrier fabrics, breathable materials, reinforced designs, and export-grade quality consistency. India and Southeast Asia are attracting attention for supply-chain diversification, while Japan and South Korea emphasize technical performance and high-quality protective apparel.

JAPAN Surgical and Isolation Gown Market

Japan accounts for approximately 4%–6% of the Asia-Pacific Surgical and Isolation Gown Market and around 1%–2% of global demand. Its mature healthcare infrastructure, aging population, high clinical quality standards, and extensive hospital network support steady protective-apparel consumption. Japanese hospitals place considerable emphasis on comfort, fit, material consistency, contamination control, and ease of use. Disposable gowns are dominant in high-risk and high-throughput clinical applications, while reusable products remain relevant where established sterilization processes are available. Approximately 60%–70% of gown procurement is estimated to involve disposable formats. Manufacturers increasingly focus on lightweight nonwoven materials, low-lint performance, breathable construction, and ergonomic sizing. Japan also provides opportunities for premium specialized gowns designed for complex surgery and infection isolation. Sustainability and packaging efficiency are becoming increasingly relevant as healthcare organizations seek to balance clinical safety with waste-management requirements.

CHINA Surgical and Isolation Gown Market

China represents approximately 10%–13% of the Asia-Pacific Surgical and Isolation Gown Market and about 3%–4% of global demand. Its large hospital network, extensive healthcare workforce, expanding medical infrastructure, and substantial manufacturing base support both domestic consumption and international supply. Disposable gowns account for a large proportion of demand, particularly in hospitals, isolation departments, operating rooms, and emergency facilities. Approximately 65%–75% of gown consumption is estimated to involve disposable formats across high-volume clinical settings. Chinese manufacturers increasingly compete through large-scale production, material efficiency, broad sizing, and specialized barrier performance. Demand is also supported by expansion of healthcare capacity beyond major metropolitan areas. Product development is shifting toward breathable multilayer nonwovens, stronger seams, reinforced protection zones, and improved packaging. China remains important not only as a demand center but also as a major source of global surgical and isolation gown supply.

MIDDLE EAST & AFRICA

The Middle East & Africa region represents approximately 10%–15% of global Surgical and Isolation Gown Market demand when regional healthcare procurement and specialized protective-apparel consumption are combined. Demand is concentrated in Gulf healthcare systems, major urban hospitals, private medical networks, and expanding healthcare infrastructure in selected African markets. Disposable gowns are widely preferred because they simplify infection control and reduce dependence on centralized laundering facilities. Approximately 60%–75% of institutional requirements can be associated with disposable protective products. Procurement is strongly influenced by import availability, product certification, hospital capacity, emergency preparedness, and distributor networks. Gulf countries are increasing investment in advanced hospitals and surgical centers, supporting demand for higher-performance gowns. African markets offer longer-term opportunities as healthcare infrastructure expands, but affordability and supply continuity remain important constraints. Regional manufacturers and distributors can benefit from localized inventory and flexible product configurations.

List of Key Surgical and Isolation Gown Market Companies

  • Cardinal Health
  • Medline Industries
  • 3M
  • DuPont
  • Glory Medical
  • Ansell
  • INTCO
  • Owens and Minor
  • ZhenDe Medical
  • Crown Name (WH) United Co Ltd
  • Lakeland Industries
  • ALLMED
  • Hubei Wanli Protective Products Co Ltd
  • Shenzhen HisoMedical Co., Ltd
  • Hubei Fullcare Protective Products Co., Ltd
  • Hubei Healthcare Products Co Ltd
  • Fullstar Non-woven Products Co Ltd
  • Hubei Medwear Protective Products Co Ltd
  • Zhangjiagang Zhiyi Medical Health Products Co Ltd
  • Forlong Medical Co Ltd

Top Two Companies with Highest Share

  • Medline Industries: Estimated organized-market share of approximately 6%–8%.
  • Cardinal Health: Estimated organized-market share of approximately 5%–7%.

Investment Analysis and Opportunities

Investment opportunities in the Surgical and Isolation Gown Market are increasingly concentrated in high-performance disposable materials, supply-chain resilience, specialized surgical protection, and sustainable product design. Approximately 30%–40% of strategic investment priorities can be directed toward manufacturing efficiency, automation, advanced nonwoven fabrics, quality control, and capacity expansion. Companies with diversified raw-material sourcing can reduce procurement risk while improving supply continuity. Demand for fluid-resistant and reinforced gowns remains particularly attractive because higher-risk procedures require greater protective performance. Private-label manufacturing and institutional contract supply also provide opportunities for scalable volume growth.

Sustainability offers another investment pathway, with approximately 20%–30% of procurement programs increasingly considering waste reduction, lighter materials, packaging efficiency, and reusable alternatives. Investments in automated cutting, efficient fabric utilization, improved seam technology, and digital quality inspection can reduce production variability. Emerging markets offer opportunities through local manufacturing and regional distribution partnerships. Investors can also target specialized gown categories where product differentiation is stronger than in standardized basic gowns. B2B procurement platforms, hospital group contracts, and long-term supply agreements can further improve market access.

New Products Development

New product development in the Surgical and Isolation Gown Market is focused on combining barrier protection with breathability, mobility, and lower material intensity. Approximately 30%–40% of current product-development priorities can be associated with lightweight multilayer nonwovens, reinforced critical zones, improved seam construction, and ergonomic designs. Manufacturers are developing gowns with better sleeve mobility, secure cuffs, adjustable neck closures, and improved sizing consistency. Higher-protection surgical gowns increasingly use targeted reinforcement rather than adding excessive material across the entire garment. This approach can improve comfort while maintaining protection in high-risk areas.

Sustainability-oriented products are also receiving increased attention, with approximately 20%–30% of development initiatives incorporating recyclable packaging, reduced fabric use, lower-lint materials, or reusable configurations. Antimicrobial-treated fabrics and application-specific gowns are additional innovation areas, although performance validation remains essential. Product developers are also improving folding methods and packaging density to reduce transportation and storage requirements. Digital traceability, batch-level quality monitoring, and standardized labeling are gaining relevance for institutional buyers seeking greater procurement transparency and consistent product performance.

Five Recent Developments

  • Advanced Barrier Fabrics: In 2024, manufacturers increasingly emphasized multilayer nonwoven constructions designed to improve liquid resistance while preserving flexibility. Approximately 25%–35% of new product discussions focused on balancing protection with breathability, particularly for operating-room and prolonged-wear applications.
  • Sustainable Material Optimization: In 2024, manufacturers expanded development efforts around lighter fabrics, reduced packaging, and material-efficient gown patterns. Sustainability-related attributes influenced approximately 20%–30% of product-development priorities as healthcare buyers increased attention to medical-waste reduction.
  • Reinforced Surgical Protection: In 2024, specialized gown designs increasingly incorporated reinforcement around the chest, sleeves, and forearms. Approximately 20%–25% of premium surgical-gown development activity targeted higher fluid-exposure procedures and improved protection in critical zones.
  • Comfort-Focused Construction: Manufacturers increasingly introduced breathable fabrics, ergonomic sleeves, improved cuffs, and adjustable closure systems in 2024. Approximately 25%–35% of product evaluations increasingly considered wearer comfort, mobility, heat management, and fit alongside fundamental barrier performance.
  • Supply-Chain Diversification: During 2024, manufacturers and healthcare procurement organizations increasingly emphasized multi-source raw materials and regional production capabilities. Approximately 30%–40% of strategic sourcing discussions incorporated supply continuity, inventory resilience, lead-time reduction, and geographic diversification.

Report Coverage of Surgical and Isolation Gown Market

The Surgical and Isolation Gown Market Report covers market structure by product type, application, geography, material characteristics, protection requirements, and healthcare procurement channel. The assessment considers Full-back Isolation Gowns, Open-back Protective Gowns, and Others, along with Hospitals, Ambulatory and Surgical Centers, Clinics, and other healthcare applications. Market analysis also evaluates disposable and reusable product dynamics, barrier protection, fluid resistance, comfort, sustainability, manufacturing capacity, procurement patterns, and competitive positioning. Quantitative assessment emphasizes percentage-based market indicators rather than revenue or CAGR values.

The Surgical and Isolation Gown Market Analysis includes North America, Europe, Germany, the United Kingdom, Asia-Pacific, Japan, China, and Middle East & Africa. The report evaluates regional market share, demand intensity, product adoption, healthcare infrastructure, supply-chain trends, and investment opportunities. It also reviews competitive activity among major manufacturers and specialized protective-apparel suppliers. The Surgical and Isolation Gown Market Research Report is designed for B2B procurement teams, manufacturers, distributors, investors, healthcare organizations, and strategic planners seeking Surgical and Isolation Gown Market Size, Surgical and Isolation Gown Market Share, Surgical and Isolation Gown Market Growth, Surgical and Isolation Gown Market Forecast, Surgical and Isolation Gown Market Trends, Surgical and Isolation Gown Market Outlook, Surgical and Isolation Gown Market Insights, and Surgical and Isolation Gown Market Opportunities.

Surgical and Isolation Gown Market Report Coverage

REPORT COVERAGE DETAILS
Market Size Value In USD 1860.02 Million in 2026
Market Size Value By USD 2431.49 Million by 2035
Growth Rate CAGR of 3.02% from 2026 - 2035
Forecast Period 2026 - 2035
Base Year 2025
Historical Data Available Yes
Regional Scope Global
Segments Covered
By Type Full-back Isolation Gowns | Open-back Protective Gowns | Others
By Application Hospitals | Ambulatory and Surgical Centers | Clinics | Others

Frequently Asked Questions

The global Surgical and Isolation Gown Market is expected to reach USD 2431.49 Million by 2035.

The Surgical and Isolation Gown Market is expected to exhibit a CAGR of 3.02% by 2035.

Cardinal Health, Medline Industries, 3M, DuPont, Glory Medical, Ansell, INTCO, Owens and Minor, ZhenDe Medical, Crown Name (WH) United Co Ltd, Lakeland Industries, ALLMED, Hubei Wanli Protective Products Co Ltd, Shenzhen HisoMedical Co., Ltd, Hubei Fullcare Protective Products Co., Ltd, Hubei Healthcare Products Co Ltd, Fullstar Non-woven Products Co Ltd, Hubei Medwear Protective Products Co Ltd, Zhangjiagang Zhiyi Medical Health Products Co Ltd, Forlong Medical Co Ltd

In 2026, the Surgical and Isolation Gown Market is estimated at USD 1860.02 Million.

Our
Clients

Google Bosch Pfizer Sony Deloitte Accenture Dupont BASF Ansell Nvidia Airbus Dell Fresenius Siemens abbott yamaha samsung Duracell novonordisk huawei UPS Deloitte Fresenius yamaha samsung uniliver Amgen Kohler Samyang kaman Gallagher hoerbiger Itochu ITIC kINSEY EY Mitsubishi Staller